Glade Guides
Search

Glenmark Pharmaceuticals

Sector: Healthcare | Industry: Drugs & Pharma
R 633.70 -10.85 | -1.68% 18.18% 19.82 17,899.34
NSE Price: Dec 10, 14:14 Change R | % 1-Year Change P/E Market Cap (R Cr)
NSE Dec 10, 14:14 633.70 -10.85 -1.68% 638.50 644.55 599,513 631.40 - 646.00
BSE Dec 10, 14:25 633.60 -9.25 -1.44% 628.10 642.85 27,270 628.10 - 645.00
Exchange & Time Last Price Day Change Open Prev Close Volume 1-Day Range
6M Average Volume: 1,134,037 P/B: 3.26 NSE Code: GLENMARK
52-Week Range: R 493.50 - 711.90 Dividend Yield: 0.32% BSE Code: 532296
TTM EPS: R 32.01 Book Value: R 194.75 Face Value: R 1
Price Graph
  • Glaxosmithkline Pharma (NSE)
  • NIFTY 50


Please wait while we are fetching data...
Get the best stock ideas
Want to create meaningful wealth through stock investing?
Performance
YTD 1-Month 3-Month 1-Year 3-Year 5-Year 10-Year
Glenmark Pharma. 8.37 -3.16 -5.93 21.11 -12.31 4.18 7.50
NIFTY Midcap 100 -19.30 -1.99 -12.90 -14.00 8.95 17.02 17.63
NIFTY Pharma -9.75 -8.72 -18.56 -3.10 -9.62 3.34 14.46
Company's return has been calculated on basis of NSE's price.
As on Dec 07, 2018
Key Ratios
Revenue Per Share (R) Earnings Per Share (R) Return on Networth (%)


Please wait
while we are fetching data...


Please wait
while we are fetching data...


Please wait
while we are fetching data...
Annual Ratios (%)
1-Year 3-Years 5-Years
Growth
Revenue -0.06 10.75 12.80
Net Profit -27.50 56.56 5.05
EPS -27.51 54.50 4.47
Book Value 14.74 40.57 12.35
Average
Operating Margin 18.81 20.31 19.55
Net Margin 8.77 10.24 8.60
Return on Networth 16.67 23.81 19.84
Return on Investment 14.77 17.95 16.26
Interim Growth Ratios (%)
QoQ YoY YTD
Quarterly
Revenue 19.20 14.39 13.23
Operating Profit 19.56 38.71 46.32
Net Profit 77.69 93.35 173.04
EPS 77.69 93.32 173.13
TTM
Revenue 3.65 -3.97 1.40
Operating Profit 10.12 -19.33 3.18
Net Profit 28.41 -25.24 12.38
EPS 28.41 -25.25 12.38
Peer Comparison
Market Cap
(R Cr)
Revenue
(R Cr)
Net Profit
(R Cr)
Net Margin (%) RoE (%) Price to Book Price to Earnings
Glenmark Pharma. 17,899.34 9,230.43 903.36 9.45 16.67 3.26 19.82
Alkem Laboratories 23,096.37 6,842.08 644.89 9.31 13.69 4.42 36.70
Glaxosmithkline Pharma 22,450.53 3,004.49 384.60 12.54 17.26 11.74 58.37
Insider Trades
Date Person Buy / Sell Transaction
Type
No of Shares Price
(R)
Value
(R Lakhs)
Dec 06, 2018 GLENN SALDANHA Buy Market 14,179 625.50 88.69
Dec 06, 2018 GLENN SALDANHA Buy Market 1,896 625.50 11.86
Jul 02, 2018 CHERYLANN PINTO Buy Market 1,000 580.60 5.81
Jul 02, 2018 ROBIN PINTO Buy Market 2,500 580.60 14.52
Jun 06, 2018 Robin Pinto Buy Market 1,000 537.00 5.37
Fund Houses invested in the stock
Fund Sep-18 Jun-18 Mar-18 Dec-17 Sep-17
HDFC Mutual Fund 2.702 2.673 2.040 0.538 0.243
Kotak Mahindra Mutual Fund 0.395 0.336 0.006 0.394 0.380
DSP Mutual Fund 0.330 0.475 0.406 0.258 -
SBI Mutual Fund 0.258 - 0.369 0.001 -
Franklin Templeton Mutual Fund 0.228 0.228 0.228 0.228 0.228
Reliance Mutual Fund 0.177 0.253 0.248 0.316 0.453
Mahindra Mutual Fund 0.065 0.065 0.065 0.002 0.002
UTI Mutual Fund 0.056 - 0.001 0.058 0.028
Taurus Mutual Fund 0.022 0.025 - - -
IDFC Mutual Fund 0.018 0.007 - 0.136 0.145
Figures given above are % of equity capital
Review & Analysis
News & Announcements
Contact Information

Company: Glenmark Pharmaceuticals Ltd.

Address: B/2 Mahalaxmi Chambers, 22 Bhulabhai Desai Road, Mumbai, Maharashtra - 400026

Email: [email protected]

Website: glenmarkpharma.com

Registrar & Transfer Agent: Karvy Fintech Pvt Ltd.-(Karvy Computuershare Pvt Ltd.)

Address: Karvy Selenium Tower B, Plot 31-32Gachibowli,Financial District, NanakramgudaHyderabad – 500032Tel. No. 040 67161500Fax. No. 040 23001153E-mail: [email protected]: karvy.comToll Free No. of exclusive Call Centre:1-800-345001, Karvy Selenium Tower B, Plot 31-32, Gachibowli,Financial District, Nanakramguda | Phone: 91-040-67161500 | Fax: 91-040-23001153

Email: [email protected]

Website: karvy.com

comments powered by Disqus
Essential checks
Altman Z-Score
3.54
Piotroski F-Score
5
Modified C-Score
2
5-Years Price to Earnings
20.08
5-Years Price to Book
3.30
Earnings Yield
EBIT / Enterprise value
7.51%
PEG
Price / Earnings to growth ratio
3.27
Related Stocks
Current Price Chng %
Abbott India R7,305.00 -2.54%
Alembic Pharmaceuticals R613.00 -0.49%
Alkem Laboratories R1,928.40 +1.82%
Bayer CropScience R4,305.60 +0.15%
Glaxosmithkline Pharma R1,330.15 -1.77%
Jubilant Life Sciences R748.70 -5.44%
Natco Pharma R699.80 -2.11%
Pfizer R2,719.00 -1.83%
Sanofi India R6,020.00 -1.85%
Syngene International R531.85 -1.51%
As on Dec 10, 14:14